Previous Page
continued from page 15
Group-Specific Use Recommendations
When Presenting to Patients
through their union or human resources department.
promoting chiropractic-friendly policy and legislation.
When Presenting to Legislators
management.
managed by chiropractic care.
with respect to opioid use over the years, and that chiropractic-friendly policies and legislation are required.
When Presenting to Payers
effectiveness and insurance cost savings with chiropractic care inclusion (JMPT 2005), ACF 2017 Low Back Pain Practice Guideline, etc.*
When Sharing with GP & Specialty Medical Providers **
options for pain management, especially back and neck pain
access to reasonable pain management care options.
CMT pain management, such as rehabilitation/exercise, patient cognitive-behavioral therapy integration, etc.
(using the Optum study, etc.*).
When Sharing with Non-medical Providers
options for pain management, especially back and neck pain.
access to reasonable pain management care options.
NMS conservative care specialist.
* Contact the WSCA if any of these studies or information is needed.
** Understand that the WSCA Opioid brochure contrasts the differences between medical and chiropractic practice. It may produce a defensive reaction in some medical circles. Keep your focus patient-centered. Handle this strategically by personalizing your message, and working to improve your own interprofessional relationships. Discuss the brochure as a third-party publication (not your own) and center the discussion on patient care. It is best to make sure you have a good understanding about the complexities of pain and chronic pain, and have a range of strategies in place in your practice to address various pain management issues (rehabilitation pathways, MD care coordination, patient engagement, etc.).